Equities

Nightingale Health Oyj

Nightingale Health Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)3.03
  • Today's Change-0.300 / -9.01%
  • Shares traded273.91k
  • 1 Year change+183.18%
  • Beta2.1327
Data delayed at least 15 minutes, as of Sep 23 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform0
Hold1
Sell1
Strong Sell0

Share price forecast in EUR

The 2 analysts offering 12 month price targets for Nightingale Health Oyj have a median target of 1.30, with a high estimate of 1.60 and a low estimate of 1.00. The median estimate represents a -57.10% decrease from the last price of 3.03.
High-47.2%1.60
Med-57.1%1.30
Low-67.0%1.00

Earnings history & estimates in EUR

Nightingale Health Oyj reported annual 2024 losses of -0.29 per share on Sep 20, 2024.
Average growth rate-2.78%
More ▼

Revenue history & estimates in EUR

Nightingale Health Oyj had 4th quarter 2024 revenues of 2.64m. This missed the 3.00m estimate of the one analyst following the company. The same period last year the company did not report revenues.
Nightingale Health Oyj had revenues for the full year 2024 of 4.36m. This was 4.21% above the prior year's results.
Average growth rate+33.28%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.